About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

ProPhase Arbitration Ruling Handed Down

November 16, 2016

Click here to read more

Post navigation

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

Related Posts

Phosphagenics Licencing Agreement Update

September 10, 2018

Phosphagenics Featured on The RedChip Money Report Airing on Bloomberg

April 8, 2016

Dosing Commences for CBD Topical Osteoarthritis Study

March 1, 2022March 2, 2022

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.